Prosecution Insights
Last updated: May 29, 2026

BOEHRINGER INGELHEIM VETMEDICA GMBH

8 pending office actions • 8 art units • 8 examiners • 0 of 8 (0%) have an AI response strategy ready • 10 patents granted in the last 365 days

Portfolio Summary

8
Total Pending OAs
4
Non-Final OAs
3
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 8 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

3
Overdue
0
Due this week
3
Due this month
2
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 8 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (3)Due ≤ 30 days (3)Due ≤ 60 days (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
4
Medium (50%)
0
Easy (0%)
4
Unknown (50%)

Rejection Statute Mix

BucketCases
§103 only4 (50%)
No statute on record4 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

5
Life Sciences
62% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
12% of docket
2
Mechanical / Eng
25% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

80 h
Manual time on pending OAs
16 h
Time saved (low, 20%)
28 h
Time saved (mid, 35%)
0.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
TANINGCO, MARCUS H 1 80.9% +6.5%
LAU, JONATHAN S 1 63.8% -18.5%
BRAUN, MADELINE E 1 68.0% +24.9%
TAWFIK, SAMEH 1 63.0% +30.9%
FOLEY, SHANON A 1 73.7% +18.1%
COPPINS, JANET L 1 73.4% +25.0%
GONG, KRIS HANYU 1 20.7% +63.0%
OTTON, ALICIA L 1 65.0% +9.0%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18575214 OPTICAL SYSTEM AND METHODS OF USE TANINGCO, MARCUS H 60d overdue

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17701009 INHALER GONG, KRIS HANYU 3d overdue

Interview Candidates (5)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
18473911 ADMINISTRATION PACKAGING, PRODUCTION APPARATUS AND PRODUCTION METHOD TAWFIK, SAMEH 86d overdue
17701009 INHALER GONG, KRIS HANYU 3d overdue
18481566 PHARMACEUTICAL FORMULATION COMPRISING CICLESONIDE BRAUN, MADELINE E 20d
17758427 CICLESONIDE FOR AMELIORATING QUALITY OF LIFE (QOL) IN EQUINES COPPINS, JANET L 27d
18295675 IMMUNOGENIC COMPOSITION USEFUL FOR VACCINATION AGAINST ROTAVIRUS FOLEY, SHANON A 55d

Top Art Units

Art UnitApps
2884 1
1693 1
1624 1
3731 1
1671 1
1628 1
3785 1
1699 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18575214 OPTICAL SYSTEM AND METHODS OF USE TANINGCO, MARCUS H 2884 §103 Non-Final OA 60d overdue Pending Dec 28, 2023
18482334 USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREATMENT OF CARDIAC DISEASES IN FELINES LAU, JONATHAN S 1693 Other Non-Final OA 34d Pending Oct 06, 2023
18481566 PHARMACEUTICAL FORMULATION COMPRISING CICLESONIDE BRAUN, MADELINE E 1624 Other Non-Final OA 20d Pending Oct 05, 2023
18473911 ADMINISTRATION PACKAGING, PRODUCTION APPARATUS AND PRODUCTION METHOD TAWFIK, SAMEH 3731 §103 Non-Final OA 86d overdue Pending Sep 25, 2023
18295675 IMMUNOGENIC COMPOSITION USEFUL FOR VACCINATION AGAINST ROTAVIRUS FOLEY, SHANON A 1671 Other Final Rejection 55d Pending Apr 04, 2023
17758427 CICLESONIDE FOR AMELIORATING QUALITY OF LIFE (QOL) IN EQUINES COPPINS, JANET L 1628 Other Final Rejection 27d Pending Jul 06, 2022
17701009 INHALER GONG, KRIS HANYU 3785 §103 Non-Final OA 3d overdue Pending Mar 22, 2022
17131312 ANGIOTENSIN II RECEPTOR ANTAGONIST FOR THE PREVENTION OR TREATMENT OF SYSTEMIC DISEASES IN CATS OTTON, ALICIA L 1699 §103 Final Rejection 27d Pending Dec 22, 2020

Managing BOEHRINGER INGELHEIM VETMEDICA GMBH's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month